Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells
| Autor: | Shimpei Ogawa, Yasuhiko Sato, Hiroaki Ayabe, Masaru Koido, Akira Mori, Emi Yoshizawa, Yoko Ejiri, Keisuke Sekine, Shizuka Funayama, Kohei Nozawa, Momotaro Ishikawa, Tatsuya Kobayashi, Toshiharu Kasai, Rina Kitada, Satoshi Okamoto, Noriko Nakanishi, Tomoko Hisai, Yasujiro Kiyota, Yosuke Yamazaki, Masaki Kimura, Satoru Ayano, Takanori Takebe, Naoki Amimoto, Yasuharu Ueno, Hideki Taniguchi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Pluripotent Stem Cells Mesenchyme Induced Pluripotent Stem Cells Cell Differentiation Biology General Biochemistry Genetics and Molecular Biology Cell biology Transplantation Organoids 03 medical and health sciences 030104 developmental biology medicine.anatomical_structure Liver lcsh:Biology (General) Homogeneous medicine Organoid Humans Endoderm Human Induced Pluripotent Stem Cells Induced pluripotent stem cell lcsh:QH301-705.5 Cells Cultured Progenitor |
| Zdroj: | Cell Reports, Vol 21, Iss 10, Pp 2661-2670 (2017) |
| ISSN: | 2211-1247 |
| Popis: | Summary: Organoid technology provides a revolutionary paradigm toward therapy but has yet to be applied in humans, mainly because of reproducibility and scalability challenges. Here, we overcome these limitations by evolving a scalable organ bud production platform entirely from human induced pluripotent stem cells (iPSC). By conducting massive “reverse” screen experiments, we identified three progenitor populations that can effectively generate liver buds in a highly reproducible manner: hepatic endoderm, endothelium, and septum mesenchyme. Furthermore, we achieved human scalability by developing an omni-well-array culture platform for mass producing homogeneous and miniaturized liver buds on a clinically relevant large scale (>108). Vascularized and functional liver tissues generated entirely from iPSCs significantly improved subsequent hepatic functionalization potentiated by stage-matched developmental progenitor interactions, enabling functional rescue against acute liver failure via transplantation. Overall, our study provides a stringent manufacturing platform for multicellular organoid supply, thus facilitating clinical and pharmaceutical applications especially for the treatment of liver diseases through multi-industrial collaborations. : With the goal of clinical translation of liver bud transplant therapy, Takebe et al. established a massive organoid production platform from endoderm, endothelial, and mesenchymal progenitor populations specified entirely from human iPSCs, reproducibly demonstrating functionality both in vitro and in vivo. Keywords: iPSC, liver bud, organoid, transplantation, self-organization, endothelial, mesenchymal, liver failure, clinical grade |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|